Pharmaceutical companies around the world are under strict watch by regulatory bodies like the FDA and EMA. This is largely […]
How Should a CRO Help with Your Nitrosamine Risk Evaluation? Read More »
Introduction In the pharmaceutical world, keeping drugs safe from harmful impurities like nitrosamines is now more important than ever. That’s
How to Perform a Nitrosamine Risk Assessment for Your Drug Product Read More »
Pharmaceutical companies worldwide are under increasing regulatory pressure to assess, mitigate, and report the risk of nitrosamine impurities in drug
The presence of nitrosamine impurities in pharmaceutical products has raised significant regulatory concerns globally, pushing the need for reliable, science-driven
Introduction: The Rising Need for Nitrosamine Impurity Testing for Drug Products Nitrosamines have emerged as a major safety concern in
Eliminating Risk: Comprehensive Nitrosamine Impurity Testing for Drug Products Read More »
Introduction The demand for Nitrosamine Risk Assessment in Canada has increased significantly as pharmaceutical manufacturers must comply with Health Canada’s
Best Laboratory for Nitrosamine Risk Assessment in Canada Read More »
